Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
LIVER
Publication-derived

Biliary Organoids for Drug Screening with Enhanced Maturation (LV-DS-24)

Source Budi et al., 2024 · Taipei Medical University · DOI

Duration: 28 days Cell source: Human iPSC, Human ESC Full SOP · 6 phases · QC included
Drug screening
LV-DS-24 Full SOP with Academic or a plan
BRAIN
Publication-derived

Autism Spectrum Disorder and Schizophrenia Cortical Organoids (BN-DS-12)

Source Mariani et al., 2012 · DOI

Duration: 70 days Cell source: Patient-Derived iPSC (Autism/Schizophrenia risk variant carriers) Full SOP · 7 phases · QC included
Disease modelling
BN-DS-12 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Degeneration Organoids (RT-DS-22)

Source Koukourakis et al., 2022 · TU Dresden (Laboratory for Measurement and Sensorsystem Technique, Competence Center for Biomedical Laser Systems) · DOI

Duration: 231 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Disease modelling
RT-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Meningioma Brain Bioprinted and Engineered Tissues (BN-DS-25)

Source Andersen et al., 2025 · Department of Neurosurgery, Odense University Hospital, University of Southern Denmark · DOI

Duration: 210 days Cell source: Patient-Derived iPSC (Meningioma) Full SOP · 6 phases · QC included
Drug screening
BN-DS-25 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Microvillus Inclusion Disease Intestinal Organoids (IN-DS-14)

Source Wigerninck et al., 2014 · University Medical Center Utrecht, Department of Pediatric Gastroenterology, Wilhelmina Children's Hospital · DOI

Duration: 230 days Cell source: Patient-Derived iPSC (Microvillus Inclusion Disease) Full SOP · 9 phases · QC included
Disease modelling
IN-DS-14 Full SOP with Academic or a plan
BRAIN
Publication-derived

Midbrain Organoids for Drug Screening (BN-DS-20)

Source Renner et al., 2020 · Max Planck Institute for Molecular Biomedicine, Münster, Germany · DOI

Duration: 59 days Cell source: Patient-Derived iPSC (from same line as smNPCs, human midbrain-specific neural precursor cells) Full SOP · 11 phases · QC included
Drug screening
BN-DS-20 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatitis B Liver Organoids for Infection Studies (LV-DS-25)

Source Eugène, 2025 · Université de Montréal · DOI

Duration: 25 days Cell source: Human iPSC Full SOP · 10 phases · QC included
Disease modelling
LV-DS-25 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatitis E Liver Organoids (LV-DS-25)

Source Liu et al., 2025 · State Key Laboratory of Drug Regulatory Science, National Institutes for Food and Drug Control, Beijing, China · DOI

Duration: 60 days Cell source: Human iPSC Full SOP · 10 phases · QC included
Drug screening
LV-DS-25 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids with Gene Editing (IN-CA-15)

Source Drost et al., 2015 · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht · DOI

Duration: 70 days Cell source: Human small intestinal and colon stem cells from endoscopic biopsies Full SOP · 8 phases · QC included
Disease modelling
IN-CA-15 Full SOP with Academic or a plan
BRAIN
Publication-derived

Frontotemporal Dementia Cerebral Organoids for Disease Modelling (BN-DS-21)

Source Bowles et al., 2021 · Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai · DOI

Duration: 180 days Cell source: Patient-Derived iPSC (tau-V337M frontotemporal dementia) Full SOP · 4 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Glioblastoma Brain Organoids (2021) (BN-DS-21)

Source Azzarelli et al., 2021 · Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge · DOI

Duration: 42 days Cell source: Human iPSC (BobC, FSPS-13B, IMR-90) and Patient-Derived GSCs (GCGR-E27, GCGR-E35) Full SOP · 5 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Aicardi-Goutières Syndrome Cortical Organoids (BN-DS-17)

Source Thomas et al., 2017 · University of California, San Diego · DOI

Duration: 60 days Cell source: Human ESC and Patient-Derived iPSC (Aicardi-Goutières syndrome) Full SOP · 17 phases
Disease modelling
BN-DS-17 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening and Transplantation (LV-DS-18)

Source Hu et al., 2018 · Hubrecht Institute, KNAW, Utrecht, the Netherlands · DOI

Duration: 140 days Cell source: Mouse primary hepatocytes; Human fetal hepatocytes (11-20 weeks gestation); Human primary hepatocytes (pediatric and adult) Full SOP · 7 phases · QC included
Drug screening
LV-DS-18 Full SOP with Academic or a plan
MUSCLE
Publication-derived

Amyotrophic Lateral Sclerosis Muscle Organoids (MU-DS-24)

Source Gao et al., 2024 · Westlake University, Hangzhou, Zhejiang, China · DOI

Duration: 105 days Cell source: Patient-Derived iPSC (C9orf72-ALS) Full SOP · 5 phases · QC included
Disease modelling
MU-DS-24 Full SOP with Academic or a plan
BRAIN
Publication-derived

Familial Alzheimer's Disease Cerebral Organoids (BN-DS-19)

Source Ghatak et al., 2019 · The Scripps Research Institute, Department of Molecular Medicine · DOI

Duration: 60 days Cell source: Patient-Derived iPSC (Familial Alzheimer's Disease - PS1 ΔE9, PS1 M146V, APP Swedish) Full SOP · 13 phases · QC included
Disease modelling
BN-DS-19 Full SOP with Academic or a plan
ESOPHAGEAL
Publication-derived

Oesophageal Organoids for Drug Screening (ES-DS-18)

Source Li et al., 2018 · MRC Cancer Unit, University of Cambridge · DOI

Duration: 7 days Cell source: Patient-Derived Cancer Tissue (Esophageal Adenocarcinoma) Full SOP · 8 phases · QC included
Drug screening
ES-DS-18 Full SOP with Academic or a plan
BRAIN
Publication-derived

Alzheimer's Disease Brain Organoids for Drug Screening (BN-DS-20)

Source Choi et al., 2020 · Department of Biochemistry and Biomedical Sciences, College of Medicine, Seoul National University · DOI

Duration: 70 days Cell source: Patient-Derived iPSC (Alzheimer's disease) Full SOP · 9 phases · QC included
Drug screening
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Sonic Hedgehog Medulloblastoma Hindbrain Organoids (BN-CA-25)

Source van Essen et al., 2025 · Nuffield Department of Clinical Neurosciences, University of Oxford Medical Sciences Division · DOI

Duration: 60 days Cell source: Human iPSC-derived cerebellar organoids co-cultured with SHH-MB cell lines (DAOY, ONS-76) Full SOP · 5 phases · QC included
Disease modelling
BN-CA-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Spinal Cord Organoids for Drug Screening and Toxicity Testing

Source Lee et al. · Department of Anatomy, Brain Korea 21 Plus Program for Biomedical Science, Korea University College of Medicine, Seoul, Republic of Korea · DOI

Duration: 140 days Cell source: Human ESC (H9-GFP) and Human iPSC (#5-1, #56-2, AICS-0023) Full SOP · 5 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organoids for Developmental Studies (2021) (BN-DS-21)

Source Wulansari et al., 2021 · Hanyang University · DOI

Duration: 50 days Cell source: Human ESC Full SOP · 8 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Fragile X Syndrome Cortical Organoids (BN-DS-21)

Source Kang et al., 2021 · Emory University School of Medicine · DOI

Duration: 71 days Cell source: Patient-Derived iPSC (Fragile X Syndrome) Full SOP · 8 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Gastric Organoids for Infection and Disease Modelling (GS-TX-15)

Source Huang et al., 2015 · Stanford University School of Medicine · DOI

Duration: 42 days Cell source: Human gastric epithelial cells (from surgical specimens) Full SOP · 12 phases · QC included
Infectious disease
GS-TX-15 Full SOP with Academic or a plan
BRAIN
Publication-derived

Opioid Use Disorder Cortical Organoids (BN-DS-24)

Source Ho et al., 2024 · Mayo Clinic, Rochester, MN, USA · DOI

Duration: 90 days Cell source: Patient-Derived iPSC (Opioid Use Disorder) Full SOP · 11 phases · QC included
Drug screening
BN-DS-24 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Gastric Organoids for Disease Modelling (GS-DS-17)

Source Mccracken et al., 2017 · Cincinnati Children's Hospital Medical Center · DOI

Duration: 34 days Cell source: Human iPSC (H1 hESC-derived) Full SOP · 5 phases · QC included
Disease modelling
GS-DS-17 Full SOP with Academic or a plan